SSI prevention: how can we strive for zero?
Clinical decision-makers are continuously forced to make tradeoffs. This includes limiting the use of new technologies that could benefit wider patient groups, despite proven clinical efficacy.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.